These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37541367)

  • 1. Past and present of beta arrestins: A new perspective on insulin secretion and effect.
    Guven B; Onay-Besikci A
    Eur J Pharmacol; 2023 Oct; 956():175952. PubMed ID: 37541367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.
    Sonoda N; Imamura T; Yoshizaki T; Babendure JL; Lu JC; Olefsky JM
    Proc Natl Acad Sci U S A; 2008 May; 105(18):6614-9. PubMed ID: 18445652
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Wang J; Pani B; Gokhan I; Xiong X; Kahsai AW; Jiang H; Ahn S; Lefkowitz RJ; Rockman HA
    Mol Pharmacol; 2021 Dec; 100(6):568-579. PubMed ID: 34561298
    [No Abstract]   [Full Text] [Related]  

  • 5. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
    Bohinc BN; Gesty-Palmer D
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice.
    Ravier MA; Leduc M; Richard J; Linck N; Varrault A; Pirot N; Roussel MM; Bockaert J; Dalle S; Bertrand G
    Diabetologia; 2014 Mar; 57(3):532-41. PubMed ID: 24317793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-arrestin-biased agonism of β-adrenergic receptor regulates Dicer-mediated microRNA maturation to promote cardioprotective signaling.
    Teoh JP; Bayoumi AS; Aonuma T; Xu Y; Johnson JA; Su H; Weintraub NL; Tang Y; Kim IM
    J Mol Cell Cardiol; 2018 May; 118():225-236. PubMed ID: 29627294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of carvedilol through β-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts.
    Güven B; Kara Z; Onay-Beşikci A
    Br J Pharmacol; 2020 Dec; 177(24):5580-5594. PubMed ID: 32931611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Arrestin signal complex plays a critical role in adipose differentiation.
    Santos-Zas I; Lodeiro M; Gurriarán-Rodríguez U; Bouzo-Lorenzo M; Mosteiro CS; Casanueva FF; Casabiell X; Pazos Y; Camiña JP
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1281-92. PubMed ID: 23557604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biased Signaling through G Protein-coupled Receptors].
    Kurose H
    Yakugaku Zasshi; 2022; 142(10):1091-1101. PubMed ID: 36184444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Arrestins: multifunctional signaling adaptors in type 2 diabetes.
    Feng X; Wang W; Liu J; Liu Y
    Mol Biol Rep; 2011 Apr; 38(4):2517-28. PubMed ID: 21086182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
    Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
    J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1.
    Kong KC; Butcher AJ; McWilliams P; Jones D; Wess J; Hamdan FF; Werry T; Rosethorne EM; Charlton SJ; Munson SE; Cragg HA; Smart AD; Tobin AB
    Proc Natl Acad Sci U S A; 2010 Dec; 107(49):21181-6. PubMed ID: 21078968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
    Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
    Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-arrestin biased agonism/antagonism at cardiovascular seven transmembrane-spanning receptors.
    Lymperopoulos A
    Curr Pharm Des; 2012; 18(2):192-8. PubMed ID: 22229558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Violin JD; Lefkowitz RJ
    Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
    Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance.
    Luan B; Zhao J; Wu H; Duan B; Shu G; Wang X; Li D; Jia W; Kang J; Pei G
    Nature; 2009 Feb; 457(7233):1146-9. PubMed ID: 19122674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.
    Wisler JW; DeWire SM; Whalen EJ; Violin JD; Drake MT; Ahn S; Shenoy SK; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16657-62. PubMed ID: 17925438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-arrestin-mediated signaling improves the efficacy of therapeutics.
    Ibrahim IA; Kurose H
    J Pharmacol Sci; 2012; 118(4):408-12. PubMed ID: 22447307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.